Skip to content
Back to ICE

Intercontinental Exchange, Inc.

Open-market purchases and sales reported on SEC Forms 4 and 5, with each filing and its footnotes.

Since Nov 17, 2025
Transactions
76
Purchases
0
Sales
76
Purchase value
$0.00
Sale value
$95.70M

Values are shares multiplied by reported price when both were supplied, each trade counted once however many filers reported it.

Mayur KapaniChief Technology Officer
4Rule 10b5-1 plan disclosed
Filed Nov 13, 2026Period of report Nov 11, 20260001193125-26-460766
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleNov 11, 2026
Common StockF1F2400$176.90$70.76K73,352Direct
SaleNov 11, 2026
Common StockF1F31,300$178.1685$231.62K72,052Direct
SaleNov 11, 2026
Common StockF1F42,000$179.698$359.40K70,052Direct
SaleNov 11, 2026
Common StockF1F5F6F7F8572$180.3121$103.14K69,480Direct
Filing footnotes · 9
  1. F1This transaction was effected pursuant to a Rule 10b5-l trading plan which was approved and became effective as of February 12, 2026.
  2. F2The price range for the aggregate amount sold by the direct holder is $176.55 - $177.15. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price.
  3. F3The price range for the aggregate amount sold by the direct holder is $177.81 - $178.80. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price.
  4. F4The price range for the aggregate amount sold by the direct holder is $179.18 - $180.17. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price.
  5. F5The price range for the aggregate amount sold by the direct holder is $180.22 - $180.50. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price.
  6. F6The common stock number referred in Table I is an aggregate number and represents 58,271 shares of common stock, 8,907 unvested restricted stock units ("RSUs"), and 2,302 performance based restricted stock units ("PSUs"), for which the performance period has been satisfied. The RSUs and PSUs vest over a three-year period, in which 33.33% of the units vest each year.
  7. F7The satisfaction of the 2024, 2025 and 2026 three-year total shareholder return ("TSR") PSUs and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2027, February 2028 and February 2029, respectively, and will be reported at the time of vesting. The satisfaction of the 2024, 2025 and 2026 three-year earnings before interest, taxes, depreciation, and amortization ("EBITDA") PSUs and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2027, February 2028 and February 2029, respectively, and will be reported at the time of vesting.
  8. F8The satisfaction of the performance based restricted stock units granted as Deal Incentive Awards and the corresponding number of shares to be issued pursuant to these awards, will not be determined until December 2026, December 2027 and December 2028 and will be subject to additional time-based vesting conditions and, if applicable, a subsequent one-year holding period.
  9. F9These options are fully vested.
Open on SEC EDGAR
Andrew J SurdykowskiGeneral Counsel
4Rule 10b5-1 plan disclosed
Filed Nov 12, 2026Period of report Nov 10, 20260001193125-26-458546
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleNov 10, 2026
Common StockF1F22,018$174.0421$351.22K43,111Direct
SaleNov 10, 2026
Common StockF1F32,000$175.741$351.48K41,111Direct
SaleNov 10, 2026
Common StockF1F4F5F6F7557$176.2152$98.15K40,554Direct
Filing footnotes · 8
  1. F1This transaction was effected pursuant to a Rule 10b5-1 trading plan which was approved and became effective as of November 25, 2025.
  2. F2The price range for the aggregate amount sold by the direct holder is $173.87 - $174.81. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price.
  3. F3The price range for the aggregate amount sold by the direct holder is $175.14 - $176.05. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price.
  4. F4The price range for the aggregate amount sold by the direct holder is $176.18 - $176.24. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price.
  5. F5The common stock number referred in Table I is an aggregate number and represents 33,380 shares of common stock and 5,734 unvested restricted stock units ("RSUs"), and 1,440 performance based restricted stock units ("PSUs"), for which the performance period has been satisfied. The RSUs and PSUs vest over a three-year period, in which 33.33% of the units vest each year.
  6. F6The satisfaction of the 2024, 2025 and 2026 TSR PSUs and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2027, February 2028 and February 2029, respectively, and will be reported at the time of vesting. The satisfaction of the 2024, 2025 and 2026 three-year earnings before interest, taxes, depreciation, and amortization ("EBITDA") PSUs and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2027, February 2028 and February 2029, respectively, and will be reported at the time of vesting.
  7. F7The satisfaction of the performance based restricted stock units granted as Deal Incentive Awards and the corresponding number of shares to be issued pursuant to these awards, will not be determined until December 2026, December 2027 and December 2028 and will be subject to additional time-based vesting conditions and, if applicable, a subsequent one-year holding period.
  8. F8These options are fully vested.
Open on SEC EDGAR
Sharon BowenDirector
4
Filed Nov 12, 2026Period of report Nov 9, 20260001193125-26-458537
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleNov 9, 2026
Common StockF12,100$174.5102$366.47K12,977Direct
Filing footnotes · 1
  1. F1The common stock number referred in Table 1 is an aggregate number and represents 11,439 shares of common stock and 1,538 restricted stock units of the Issuer. The restricted stock units vest on the one-year anniversary of the grant date, which is May 18, 2027.
Open on SEC EDGAR
Benjamin JacksonPresident
4Rule 10b5-1 plan disclosed
Filed Nov 6, 2026Period of report Nov 4, 20260001193125-26-451918
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleNov 5, 2026
Common StockF1F3F4F5400$177.90$71.16K156,532Direct
SaleNov 4, 2026
Common StockF1F27,332$175.0072$1.28M156,932Direct
Filing footnotes · 5
  1. F1This transaction was effected pursuant to a Rule 10b5-1 trading plan which was approved and became effective as of November 3, 2025.
  2. F2The price range for the aggregate amount sold by the direct holder is $175.00 - $175.04. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price.
  3. F3The common stock number referred in Table I is an aggregate number and represents 134,533 shares of common stock and 17,204 unvested restricted stock units ("RSUs"), and 4,795 performance based restricted stock units ("PSUs"), for which the performance period has been satisfied. The RSUs and PSUs vest over a three-year period, in which 33.33% of the units vest each year.
  4. F4The satisfaction of the 2024, 2025 and 2026 three-year total shareholder return (TSR) PSUs and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2027, February 2028 and February 2029, respectively, and will be reported at the time of vesting. The satisfaction of the 2024, 2025 and 2026 year-three earnings before interest, taxes, depreciation, and amortization (EBITDA) PSUs and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2027, February 2028 and February 2029, respectively, and will be reported at the time of vesting.
  5. F5The satisfaction of the performance based restricted stock units granted as Deal Incentive Awards and the corresponding number of shares to be issued pursuant to these awards, will not be determined until December 2026, December 2027 and December 2028 and will be subject to additional time-based vesting conditions and, if applicable, a subsequent one-year holding period.
Open on SEC EDGAR
James W NamkungChief Accounting Officer
4Rule 10b5-1 plan disclosed
Filed Nov 6, 2026Period of report Nov 4, 20260001193125-26-451923
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleNov 4, 2026
Common StockF1F2F3F43,777$175.00$660.98K10,325Direct
Filing footnotes · 4
  1. F1This transaction was effected pursuant to a Rule 10b5-1 trading plan which was approved and became effective as of June 3, 2026.
  2. F2The common stock number referred in Table I is an aggregate number and represents 7,395 shares of common stock and 2,354 unvested restricted stock units ("RSUs"), and 576 performance based restricted stock units ("PSUs"), for which the performance period has been satisfied. The RSUs and PSUs vest over a three-year period, in which 33.33% of the units vest each year.
  3. F3The satisfaction of the 2024, 2025 and 2026 TSR PSUs and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2027, February 2028 and February 2029, respectively, and will be reported at the time of vesting. The satisfaction of the 2024, 2025 and 2026 three-year earnings before interest, taxes, depreciation, and amortization ("EBITDA") PSUs and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2027, February 2028 and February 2029, respectively, and will be reported at the time of vesting.
  4. F4The satisfaction of the performance based restricted stock units granted as Deal Incentive Awards and the corresponding number of shares to be issued pursuant to these awards, will not be determined until December 2026, December 2027 and December 2028 and will be subject to additional time-based vesting conditions and, if applicable, a subsequent one-year holding period.
Open on SEC EDGAR
Elizabeth Kathryn KingGlobal Head of Clearing & CRO
4Rule 10b5-1 plan disclosed
Filed Nov 6, 2026Period of report Nov 4, 20260001193125-26-451916
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleNov 4, 2026
Common Stock HoldingF1F2F3F41,919$175.00$335.83K21,835Direct
Filing footnotes · 4
  1. F1This transaction was effected pursuant to a Rule 10b5-1 trading plan which was approved and became effective as of February 6, 2026.
  2. F2Amount of securities beneficially owned includes 101 shares acquired under Intercontinental Exchange, Inc. Employee Stock Purchase Plan on June 30, 2026.
  3. F3The common stock number referred in Table I is an aggregate number and represents 14,661 shares of common stock and 5,734 unvested restricted stock units ("RSUs"), and 1,440 performance based restricted stock units ("PSUs"), for which the performance period has been satisfied. The RSUs and PSUs vest over a three-year period, in which 33.33% of the units vest each year.
  4. F4The satisfaction of the 2024, 2025 and 2026 TSR PSUs and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2027, February 2028 and February 2029, respectively, and will be reported at the time of vesting. The satisfaction of the 2024, 2025 and 2026 three-year earnings before interest, taxes, depreciation, and amortization ("EBITDA") PSUs and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2027, February 2028 and February 2029, respectively, and will be reported at the time of vesting.
Open on SEC EDGAR
James W NamkungChief Accounting Officer
4Rule 10b5-1 plan disclosed
Filed Nov 2, 2026Period of report Oct 29, 20260001193125-26-443743
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleOct 29, 2026
Common StockF1F2F3F4F52,430$165.00$400.95K14,102Direct
Filing footnotes · 5
  1. F1This transaction was effected pursuant to a Rule 10b5-1 trading plan which was approved and became effective as of June 3, 2026.
  2. F2Amount of securities beneficially owned includes 101 shares acquired under Intercontinental Exchange, Inc. Employee Stock Purchase Plan on June 30, 2026.
  3. F3The common stock number referred in Table I is an aggregate number and represents 11,172 shares of common stock and 2,354 unvested restricted stock units ("RSUs"), and 576 performance based restricted stock units ("PSUs"), for which the performance period has been satisfied. The RSUs and PSUs vest over a three-year period, in which 33.33% of the units vest each year.
  4. F4The satisfaction of the 2024, 2025 and 2026 TSR PSUs and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2027, February 2028 and February 2029, respectively, and will be reported at the time of vesting. The satisfaction of the 2024, 2025 and 2026 three-year earnings before interest, taxes, depreciation, and amortization ("EBITDA") PSUs and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2027, February 2028 and February 2029, respectively, and will be reported at the time of vesting.
  5. F5The satisfaction of the performance based restricted stock units granted as Deal Incentive Awards and the corresponding number of shares to be issued pursuant to these awards, will not be determined until December 2026, December 2027 and December 2028 and will be subject to additional time-based vesting conditions and, if applicable, a subsequent one-year holding period.
Open on SEC EDGAR
Douglas FoleySVP, HR & Administration
4Rule 10b5-1 plan disclosed
Filed Sep 16, 2026Period of report Sep 14, 20260001193125-26-393127
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleSep 14, 2026
Common StockF1F2F3F41,600$160.00$256.00K15,863Direct
Filing footnotes · 4
  1. F1This transaction was effected pursuant to a Rule 10b5-1 trading plan which was approved and became effective as of November 7, 2025.
  2. F2The common stock number referred in Table I is an aggregate number and represents 11,432 shares of common stock and 3,472 unvested restricted stock units ("RSUs"), and 959 performance based restricted stock units ("PSUs"), for which the performance period has been satisfied. The RSUs and PSUs vest over a three-year period, in which 33.33% of the units vest each year.
  3. F3The satisfaction of the 2024, 2025 and 2026 three-year total shareholder return (TSR) PSUs and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2027, February 2028 and February 2029, respectively, and will be reported at the time of vesting. The satisfaction of the 2024, 2025 and 2026 year-three earnings before interest, taxes, depreciation, and amortization (EBITDA) PSUs and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2027, February 2028 and February 2029, respectively, and will be reported at the time of vesting.
  4. F4The satisfaction of the performance based restricted stock units granted as Deal Incentive Awards and the corresponding number of shares to be issued pursuant to these awards, will not be determined until December 2026, December 2027 and December 2028 and will be subject to additional time-based vesting conditions and, if applicable, a subsequent one-year holding period.
Open on SEC EDGAR
Christopher Scott EdmondsPresident, Fixed Income & Data
4Rule 10b5-1 plan disclosed
Filed Sep 3, 2026Period of report Sep 1, 20260001193125-26-381962
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleSep 1, 2026
Common StockF1F3F4F55,000$160.59$802.95K14,367Direct
Filing footnotes · 6
  1. F1This transaction was effected pursuant to a Rule 10b5-1 trading plan which was approved and became effective as of February 6, 2026.
  2. F2Amount of securities beneficially owned includes 101 shares acquired under Intercontinental Exchange, Inc. Employee Stock Purchase Plan on June 30, 2026.
  3. F3The common stock number referred in Table I is an aggregate number and represents 2,763 shares of common stock and 9,206 unvested restricted stock units ("RSUs"), and 2,398 performance based restricted stock units ("PSUs"), for which the performance period has been satisfied. The RSUs and PSUs vest over a three-year period, in which 33.33% of the units vest each year.
  4. F4The satisfaction of the 2024, 2025 and 2026 TSR PSUs and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2027, February 2028 and February 2029, respectively, and will be reported at the time of vesting. The satisfaction of the 2024, 2025 and 2026 three-year earnings before interest, taxes, depreciation, and amortization ("EBITDA") PSUs and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2027, February 2028 and February 2029, respectively, and will be reported at the time of vesting.
  5. F5The satisfaction of the performance based restricted stock units granted as Deal Incentive Awards and the corresponding number of shares to be issued pursuant to these awards, will not be determined until December 2026, December 2027 and December 2028 and will be subject to additional time-based vesting conditions and, if applicable, a subsequent one-year holding period.
  6. F6These options are fully vested.
Open on SEC EDGAR
Benjamin JacksonPresident
4Rule 10b5-1 plan disclosed
Filed Sep 3, 2026Period of report Sep 1, 20260001193125-26-381954
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleSep 1, 2026
Common StockF1F35,020$159.6835$801.61K172,106Direct
SaleSep 1, 2026
Common StockF1F46,242$160.1684$999.77K165,864Direct
SaleSep 1, 2026
Common StockF1F5F6F7F81,600$161.0513$257.68K164,264Direct
Filing footnotes · 9
  1. F1This transaction was effected pursuant to a Rule 10b5-1 trading plan which was approved and became effective as of November 3, 2025.
  2. F2Amount of securities beneficially owned includes 101 shares acquired under Intercontinental Exchange, Inc. Employee Stock Purchase Plan on June 30, 2026.
  3. F3The price range for the aggregate amount sold by the direct holder is $158.80 - $159.78. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price.
  4. F4The price range for the aggregate amount sold by the direct holder is $159.80 - $160.59. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price.
  5. F5The price range for the aggregate amount sold by the direct holder is $160.89 - $161.29. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price.
  6. F6The common stock number referred in Table I is an aggregate number and represents 142,265 shares of common stock and 17,204 unvested restricted stock units ("RSUs"), and 4,795 performance based restricted stock units ("PSUs"), for which the performance period has been satisfied. The RSUs and PSUs vest over a three-year period, in which 33.33% of the units vest each year.
  7. F7The satisfaction of the 2024, 2025 and 2026 three-year total shareholder return (TSR) PSUs and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2027, February 2028 and February 2029, respectively, and will be reported at the time of vesting. The satisfaction of the 2024, 2025 and 2026 year-three earnings before interest, taxes, depreciation, and amortization (EBITDA) PSUs and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2027, February 2028 and February 2029, respectively, and will be reported at the time of vesting.
  8. F8The satisfaction of the performance based restricted stock units granted as Deal Incentive Awards and the corresponding number of shares to be issued pursuant to these awards, will not be determined until December 2026, December 2027 and December 2028 and will be subject to additional time-based vesting conditions and, if applicable, a subsequent one-year holding period.
  9. F9These options are fully vested.
Open on SEC EDGAR
Martha A TirinnanziDirector
4Rule 10b5-1 plan disclosed
Filed Aug 28, 2026Period of report Aug 26, 20260001193125-26-374606
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleAug 26, 2026
Common StockF1F21,340$161.16$215.95K3,747Direct
Filing footnotes · 2
  1. F1This transaction was effected pursuant to a Rule 10b5-1 trading plan which was approved and became effective as of May 11, 2026.
  2. F2The common stock number referred in Table 1 is an aggregate number and represents 2,049 shares of common stock and 1,698 restricted stock units of the Issuer. The restricted stock units vest on the one-year anniversary of the grant date, which is May 18, 2027.
Open on SEC EDGAR
Andrew J SurdykowskiGeneral Counsel
4Rule 10b5-1 plan disclosed
Filed Aug 28, 2026Period of report Aug 26, 20260001193125-26-374604
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleAug 26, 2026
Common StockF1F33,974$161.6737$642.49K43,665Direct
SaleAug 26, 2026
Common StockF1F4F5F6F7600$162.3833$97.43K43,065Direct
Filing footnotes · 8
  1. F1This transaction was effected pursuant to a Rule 10b5-1 trading plan which was approved and became effective as of November 25, 2025.
  2. F2Amount of securities beneficially owned includes 101 shares acquired under Intercontinental Exchange, Inc. Employee Stock Purchase Plan on June 30, 2026.
  3. F3The price range for the aggregate amount sold by the direct holder is $161.16 - $162.14. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price.
  4. F4The price range for the aggregate amount sold by the direct holder is $162.16 - $162.95. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price.
  5. F5The common stock number referred in Table I is an aggregate number and represents 35,891 shares of common stock and 5,734 unvested restricted stock units ("RSUs"), and 1,440 performance based restricted stock units ("PSUs"), for which the performance period has been satisfied. The RSUs and PSUs vest over a three-year period, in which 33.33% of the units vest each year.
  6. F6The satisfaction of the 2024, 2025 and 2026 TSR PSUs and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2027, February 2028 and February 2029, respectively, and will be reported at the time of vesting. The satisfaction of the 2024, 2025 and 2026 three-year earnings before interest, taxes, depreciation, and amortization ("EBITDA") PSUs and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2027, February 2028 and February 2029, respectively, and will be reported at the time of vesting.
  7. F7The satisfaction of the performance based restricted stock units granted as Deal Incentive Awards and the corresponding number of shares to be issued pursuant to these awards, will not be determined until December 2026, December 2027 and December 2028 and will be subject to additional time-based vesting conditions and, if applicable, a subsequent one-year holding period.
  8. F8These options are fully vested.
Open on SEC EDGAR
Douglas FoleySVP, HR & Administration
4Rule 10b5-1 plan disclosed
Filed Aug 24, 2026Period of report Aug 20, 20260001193125-26-363664
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleAug 20, 2026
Common StockF1F2F3F41,600$160.00$256.00K17,463Direct
Filing footnotes · 4
  1. F1This transaction was effected pursuant to a Rule 10b5-1 trading plan which was approved and became effective as of November 7, 2025.
  2. F2The common stock number referred in Table I is an aggregate number and represents 13,032 shares of common stock and 3,472 unvested restricted stock units ("RSUs"), and 959 performance based restricted stock units ("PSUs"), for which the performance period has been satisfied. The RSUs and PSUs vest over a three-year period, in which 33.33% of the units vest each year.
  3. F3The satisfaction of the 2024, 2025 and 2026 three-year total shareholder return (TSR) PSUs and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2027, February 2028 and February 2029, respectively, and will be reported at the time of vesting. The satisfaction of the 2024, 2025 and 2026 year-three earnings before interest, taxes, depreciation, and amortization (EBITDA) PSUs and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2027, February 2028 and February 2029, respectively, and will be reported at the time of vesting.
  4. F4The satisfaction of the performance based restricted stock units granted as Deal Incentive Awards and the corresponding number of shares to be issued pursuant to these awards, will not be determined until December 2026, December 2027 and December 2028 and will be subject to additional time-based vesting conditions and, if applicable, a subsequent one-year holding period.
Open on SEC EDGAR
Warren GardinerChief Financial Officer
4Rule 10b5-1 plan disclosed
Filed Aug 21, 2026Period of report Aug 19, 20260001193125-26-361178
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleAug 19, 2026
Common StockF1F2F3F42,491$156.30$389.34K22,698Direct
Filing footnotes · 4
  1. F1This transaction was effected pursuant to a Rule 10b5-1 trading plan which was approved and became effective as of June 9, 2025.
  2. F2The common stock number referred in Table I is an aggregate number and represents 10,423 shares of common stock and 10,117 unvested restricted stock units ("RSUs"), and 2,158 performance based restricted stock units ("PSUs"), for which the performance period has been satisfied. The RSUs and PSUs vest over a three-year period, in which 33.33% of the units vest each year.
  3. F3The satisfaction of the 2024, 2025 and 2026 TSR PSUs and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2027, February 2028 and February 2029, respectively, and will be reported at the time of vesting. The satisfaction of the 2024, 2025 and 2026 three-year earnings before interest, taxes, depreciation, and amortization ("EBITDA") PSUs and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2027, February 2028 and February 2029, respectively, and will be reported at the time of vesting.
  4. F4The satisfaction of the performance based restricted stock units granted as Deal Incentive Awards and the corresponding number of shares to be issued pursuant to these awards, will not be determined until December 2026, December 2027 and December 2028 and will be subject to additional time-based vesting conditions and, if applicable, a subsequent one-year holding period.
Open on SEC EDGAR
Martha A TirinnanziDirector
4Rule 10b5-1 plan disclosed
Filed Aug 17, 2026Period of report Aug 13, 20260001193125-26-354149
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleAug 13, 2026
Common StockF1F2141$155.00$21.86K5,087Direct
Filing footnotes · 2
  1. F1This transaction was effected pursuant to a Rule 10b5-1 trading plan which was approved and became effective as of May 11, 2026.
  2. F2The common stock number referred in Table 1 is an aggregate number and represents 3,389 shares of common stock and 1,698 restricted stock units of the Issuer. The restricted stock units vest on the one-year anniversary of the grant date, which is May 18, 2027.
Open on SEC EDGAR
Mayur KapaniChief Technology Officer
4Rule 10b5-1 plan disclosed
Filed Aug 14, 2026Period of report Aug 12, 20260001193125-26-352393
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleAug 12, 2026
Common StockF1F3400$149.8286$59.93K71,859Direct
SaleAug 12, 2026
Common StockF1F43,771$151.3268$570.65K68,088Direct
SaleAug 12, 2026
Common StockF1F5F6F7100$151.78$15.18K67,988Direct
Filing footnotes · 8
  1. F1This transaction was effected pursuant to a Rule 10b5-l trading plan which was approved and became effective as of February 12, 2026.
  2. F2Amount of securities beneficially owned includes 91 shares acquired under Intercontinental Exchange, Inc. Employee Stock Purchase Plan on June 30, 2026.
  3. F3The price range for the aggregate amount sold by the direct holder is $149.55 - $150.25. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price.
  4. F4The price range for the aggregate amount sold by the direct holder is $150.76 - $151.71. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price.
  5. F5The common stock number referred in Table I is an aggregate number and represents 56,779 shares of common stock, 8,907 unvested restricted stock units ("RSUs"), and 2,302 performance based restricted stock units ("PSUs"), for which the performance period has been satisfied. The RSUs and PSUs vest over a three-year period, in which 33.33% of the units vest each year.
  6. F6The satisfaction of the 2024, 2025 and 2026 three-year total shareholder return ("TSR") PSUs and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2027, February 2028 and February 2029, respectively, and will be reported at the time of vesting. The satisfaction of the 2024, 2025 and 2026 three-year earnings before interest, taxes, depreciation, and amortization ("EBITDA") PSUs and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2027, February 2028 and February 2029, respectively, and will be reported at the time of vesting.
  7. F7The satisfaction of the performance based restricted stock units granted as Deal Incentive Awards and the corresponding number of shares to be issued pursuant to these awards, will not be determined until December 2026, December 2027 and December 2028 and will be subject to additional time-based vesting conditions and, if applicable, a subsequent one-year holding period.
  8. F8These options are fully vested.
Open on SEC EDGAR
Douglas FoleySVP, HR & Administration
4
Filed Aug 7, 2026Period of report Aug 5, 20260001193125-26-340345
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleAug 5, 2026
Common StockF1F2F3F47,300$148.875$1.09M19,063Direct
Filing footnotes · 4
  1. F1Amount of securities beneficially owned includes 101 shares acquired under Intercontinental Exchange, Inc. Employee Stock Purchase Plan on June 30, 2026.
  2. F2The common stock number referred in Table I is an aggregate number and represents 14,632 shares of common stock and 3,472 unvested restricted stock units ("RSUs"), and 959 performance based restricted stock units ("PSUs"), for which the performance period has been satisfied. The RSUs and PSUs vest over a three-year period, in which 33.33% of the units vest each year.
  3. F3The satisfaction of the 2024, 2025 and 2026 three-year total shareholder return (TSR) PSUs and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2027, February 2028 and February 2029, respectively, and will be reported at the time of vesting. The satisfaction of the 2024, 2025 and 2026 year-three earnings before interest, taxes, depreciation, and amortization (EBITDA) PSUs and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2027, February 2028 and February 2029, respectively, and will be reported at the time of vesting.
  4. F4The satisfaction of the performance based restricted stock units granted as Deal Incentive Awards and the corresponding number of shares to be issued pursuant to these awards, will not be determined until December 2026, December 2027 and December 2028 and will be subject to additional time-based vesting conditions and, if applicable, a subsequent one-year holding period.
Open on SEC EDGAR
Lynn C MartinPresident, NYSE Group
4Rule 10b5-1 plan disclosed
Filed Jul 20, 2026Period of report Jul 16, 20260001193125-26-308983
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleJul 16, 2026
Common StockF1F33,000$139.7455$419.24K67,302Direct
SaleJul 16, 2026
Common StockF1F43,200$140.9036$450.89K64,102Direct
SaleJul 16, 2026
Common StockF1F59,482$141.65$1.34M54,620Direct
SaleJul 16, 2026
Common StockF1F6F7F8F9200$142.3002$28.46K54,420Direct
Filing footnotes · 10
  1. F1This transaction was effected pursuant to a Rule 10b5-1 trading plan which was approved and became effective as of May 29, 2025.
  2. F10These options are fully vested.
  3. F2Amount of securities beneficially owned includes 101 shares acquired under Intercontinental Exchange, Inc. Employee Stock Purchase Plan on June 30, 2026.
  4. F3The price range for the aggregate amount sold by the direct holder is $139.23 - $140.18. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price.
  5. F4The price range for the aggregate amount sold by the direct holder is $140.26 - $141.23. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price.
  6. F5The price range for the aggregate amount sold by the direct holder is $141.27 - $142.22. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price.
  7. F6The price range for the aggregate amount sold by the direct holder is $142.30 - $142.31. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price.
  8. F7The common stock number referred in Table I is an aggregate number and represents 41,499 shares of common stock and 9,805 unvested restricted stock units ("RSUs"), and 3,116 performance based restricted stock units ("PSUs"), for which the performance period has been satisfied. The RSUs and PSUs vest over a three-year period, in which 33.33% of the units vest each year.
  9. F8The satisfaction of the 2024, 2025 and 2026 TSR PSUs and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2027, February 2028 and February 2029, respectively, and will be reported at the time of vesting. The satisfaction of the 2024, 2025 and 2026 three-year earnings before interest, taxes, depreciation, and amortization ("EBITDA") PSUs and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2027, February 2028 and February 2029, respectively, and will be reported at the time of vesting.
  10. F9The satisfaction of the performance based restricted stock units granted as Deal Incentive Awards and the corresponding number of shares to be issued pursuant to these awards, will not be determined until December 2026, December 2027 and December 2028 and will be subject to additional time-based vesting conditions and, if applicable, a subsequent one-year holding period.
Open on SEC EDGAR
William Jefferson HagueDirector
4Rule 10b5-1 plan disclosed
Filed Jun 16, 2026Period of report Jun 12, 20260001193125-26-272681
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleJun 12, 2026
Common StockF1F21,333$139.46$185.90K20,132Direct
Filing footnotes · 2
  1. F1This transaction was effected pursuant to a Rule 10b5-1 trading plan which was approved and became effective as of March 10, 2026.
  2. F2The common stock number referred in Table 1 is an aggregate number and represents 18,594 shares of common stock and 1,538 restricted stock units of the Issuer. The restricted stock units vest on the one-year anniversary of the grant date, which is May 18, 2027.
Open on SEC EDGAR
William Jefferson HagueDirector
4Rule 10b5-1 plan disclosed
Filed Jun 11, 2026Period of report Jun 9, 20260001193125-26-267913
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleJun 9, 2026
Common StockF1F291$138.50$12.60K21,465Direct
Filing footnotes · 2
  1. F1This transaction was effected pursuant to a Rule 10b5-1 trading plan which was approved and became effective as of March 10, 2026.
  2. F2The common stock number referred in Table 1 is an aggregate number and represents 19,927 shares of common stock and 1,538 restricted stock units of the Issuer. The restricted stock units vest on the one-year anniversary of the grant date, which is May 18, 2027.
Open on SEC EDGAR
Andrew J SurdykowskiGeneral Counsel
4Rule 10b5-1 plan disclosed
Filed May 28, 2026Period of report May 26, 20260001193125-26-245320
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleMay 26, 2026
Common StockF1F21,965$150.9729$296.66K48,081Direct
SaleMay 26, 2026
Common StockF1F3F4F5F62,608$151.9981$396.41K45,473Direct
Filing footnotes · 7
  1. F1This transaction was effected pursuant to a Rule 10b5-1 trading plan which was approved and became effective as of November 25, 2025.
  2. F2The price range for the aggregate amount sold by the direct holder is $150.46 - $151.45. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price.
  3. F3The price range for the aggregate amount sold by the direct holder is $151.95 - $152.00. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price.
  4. F4The common stock number referred in Table I is an aggregate number and represents 38,299 shares of common stock and 5,734 unvested restricted stock units ("RSUs"), and 1,440 performance based restricted stock units ("PSUs"), for which the performance period has been satisfied. The RSUs and PSUs vest over a three-year period, in which 33.33% of the units vest each year.
  5. F5The satisfaction of the 2024, 2025 and 2026 TSR PSUs and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2027, February 2028 and February 2029, respectively, and will be reported at the time of vesting. The satisfaction of the 2024, 2025 and 2026 three-year earnings before interest, taxes, depreciation, and amortization ("EBITDA") PSUs and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2027, February 2028 and February 2029, respectively, and will be reported at the time of vesting.
  6. F6The satisfaction of the performance based restricted stock units granted as Deal Incentive Awards and the corresponding number of shares to be issued pursuant to these awards, will not be determined until December 2026, December 2027 and December 2028 and will be subject to additional time-based vesting conditions and, if applicable, a subsequent one-year holding period.
  7. F7These options are fully vested.
Open on SEC EDGAR
Sharon BowenDirector
4Rule 10b5-1 plan disclosed
Filed May 27, 2026Period of report May 22, 20260001193125-26-241982
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleMay 22, 2026
Common StockF1F2667$151.28$100.90K15,077Direct
Filing footnotes · 2
  1. F1This transaction was effected pursuant to a Rule 10b5-1 trading plan which was approved and became effective as of February 17, 2026.
  2. F2The common stock number referred in Table 1 is an aggregate number and represents 13,539 shares of common stock and 1,538 restricted stock units of the Issuer. The restricted stock units vest on the one-year anniversary of the grant date, which is May 18, 2027.
Open on SEC EDGAR
Warren GardinerChief Financial Officer
4Rule 10b5-1 plan disclosed
Filed May 20, 2026Period of report May 19, 20260001193125-26-232700
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleMay 19, 2026
Common StockF1F2F3F42,490$156.64$390.03K25,189Direct
Filing footnotes · 4
  1. F1This transaction was effected pursuant to a Rule 10b5-1 trading plan which was approved and became effective as of June 9, 2025.
  2. F2The common stock number referred in Table I is an aggregate number and represents 12,914 shares of common stock and 10,117 unvested restricted stock units ("RSUs"), and 2,158 performance based restricted stock units ("PSUs"), for which the performance period has been satisfied. The RSUs and PSUs vest over a three-year period, in which 33.33% of the units vest each year.
  3. F3The satisfaction of the 2024, 2025 and 2026 TSR PSUs and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2027, February 2028 and February 2029, respectively, and will be reported at the time of vesting. The satisfaction of the 2024, 2025 and 2026 three-year earnings before interest, taxes, depreciation, and amortization ("EBITDA") PSUs and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2027, February 2028 and February 2029, respectively, and will be reported at the time of vesting.
  4. F4The satisfaction of the performance based restricted stock units granted as Deal Incentive Awards and the corresponding number of shares to be issued pursuant to these awards, will not be determined until December 2026, December 2027 and December 2028 and will be subject to additional time-based vesting conditions and, if applicable, a subsequent one-year holding period.
Open on SEC EDGAR
Mayur KapaniChief Technology Officer
4Rule 10b5-1 plan disclosed
Filed May 18, 2026Period of report May 14, 20260001193125-26-228986
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleMay 14, 2026
Common StockF1F22,900$155.2708$450.29K66,240Direct
SaleMay 14, 2026
Common StockF1F3F4F5F61,371$155.7346$213.51K64,869Direct
Filing footnotes · 7
  1. F1This transaction was effected pursuant to a Rule 10b5-l trading plan which was approved and became effective as of February 12, 2026.
  2. F2The price range for the aggregate amount sold by the direct holder is $154.60 - $155.59. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price.
  3. F3The price range for the aggregate amount sold by the direct holder is $155.62 - $155.96. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price.
  4. F4The common stock number referred in Table I is an aggregate number and represents 53,660 shares of common stock, 8,907 unvested restricted stock units ("RSUs"), and 2,302 performance based restricted stock units ("PSUs"), for which the performance period has been satisfied. The RSUs and PSUs vest over a three-year period, in which 33.33% of the units vest each year.
  5. F5The satisfaction of the 2024, 2025 and 2026 three-year total shareholder return ("TSR") PSUs and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2027, February 2028 and February 2029, respectively, and will be reported at the time of vesting. The satisfaction of the 2024, 2025 and 2026 three-year earnings before interest, taxes, depreciation, and amortization ("EBITDA") PSUs and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2027, February 2028 and February 2029, respectively, and will be reported at the time of vesting.
  6. F6The satisfaction of the performance based restricted stock units granted as Deal Incentive Awards and the corresponding number of shares to be issued pursuant to these awards, will not be determined until December 2026, December 2027 and December 2028 and will be subject to additional time-based vesting conditions and, if applicable, a subsequent one-year holding period.
  7. F7These options are fully vested.
Open on SEC EDGAR
Douglas FoleySVP, HR & Administration
4Rule 10b5-1 plan disclosed
Filed Mar 11, 2026Period of report Mar 9, 20260001193125-26-102262
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleMar 9, 2026
Common StockF1F2F3F41,600$164.96$263.94K26,262Direct
Filing footnotes · 4
  1. F1This transaction was effected pursuant to a Rule 10b5-1 trading plan which was approved and became effective as of November 7, 2025.
  2. F2The common stock number referred in Table I is an aggregate number and represents 21,831 shares of common stock and 3,472 unvested restricted stock units ("RSUs"), and 959 performance based restricted stock units ("PSUs"), for which the performance period has been satisfied. The RSUs and PSUs vest over a three-year period, in which 33.33% of the units vest each year.
  3. F3The satisfaction of the 2024, 2025 and 2026 three-year total shareholder return (TSR) PSUs and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2027, February 2028 and February 2029, respectively, and will be reported at the time of vesting. The satisfaction of the 2024, 2025 and 2026 year-three earnings before interest, taxes, depreciation, and amortization (EBITDA) PSUs and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2027, February 2028 and February 2029, respectively, and will be reported at the time of vesting.
  4. F4The satisfaction of the performance based restricted stock units granted as Deal Incentive Awards and the corresponding number of shares to be issued pursuant to these awards, will not be determined until December 2026, December 2027 and December 2028 and will be subject to additional time-based vesting conditions and, if applicable, a subsequent one-year holding period.
Open on SEC EDGAR
Benjamin JacksonPresident
4Rule 10b5-1 plan disclosed
Filed Mar 3, 2026Period of report Feb 27, 20260001193125-26-088326
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleFeb 27, 2026
Common StockF1F2F3F43,865$165.00$637.73K161,439Direct
Filing footnotes · 4
  1. F1This transaction was effected pursuant to a Rule 10b5-1 trading plan which was approved and became effective as of November 3, 2025.
  2. F2The common stock number referred in Table I is an aggregate number and represents 139,440 shares of common stock and 17,204 unvested restricted stock units ("RSUs"), and 4,795 performance based restricted stock units ("PSUs"), for which the performance period has been satisfied. The RSUs and PSUs vest over a three-year period, in which 33.33% of the units vest each year.
  3. F3The satisfaction of the 2024, 2025 and 2026 TSR PSUs and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2027, February 2028 and February 2029, respectively, and will be reported at the time of vesting. The satisfaction of the 2024, 2025 and 2026 three-year earnings before interest, taxes, depreciation, and amortization ("EBITDA") PSUs and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2027, February 2028 and February 2029, respectively, and will be reported at the time of vesting.
  4. F4The satisfaction of the performance based restricted stock units granted as Deal Incentive Awards and the corresponding number of shares to be issued pursuant to these awards, will not be determined until December 2026, December 2027 and December 2028 and will be subject to additional time-based vesting conditions and, if applicable, a subsequent one-year holding period.
Open on SEC EDGAR
Andrew J SurdykowskiGeneral Counsel
4Rule 10b5-1 plan disclosed
Filed Mar 2, 2026Period of report Feb 26, 20260001193125-26-085543
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleFeb 26, 2026
Common StockF1F23,099$161.7116$501.14K49,653Direct
SaleFeb 26, 2026
Common StockF1F31,472$162.6222$239.38K48,181Direct
Filing footnotes · 8
  1. F1This transaction was effected pursuant to a Rule 10b5-1 trading plan which was approved and became effective as of November 25, 2025.
  2. F2The price range for the aggregate amount sold by the direct holder is $161.37 - $162.22. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price.
  3. F3The price range for the aggregate amount sold by the direct holder is $162.42 - $162.87. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price.
  4. F4This transaction involved a gift of 200 shares of the issuer's common stock by the reporting person to a philanthropic organization.
  5. F5The common stock number referred in Table I is an aggregate number and represents 40,807 shares of common stock and 5,734 unvested restricted stock units ("RSUs"), and 1,440 performance based restricted stock units ("PSUs"), for which the performance period has been satisfied. The RSUs and PSUs vest over a three-year period, in which 33.33% of the units vest each year.
  6. F6The satisfaction of the 2024, 2025 and 2026 TSR PSUs and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2027, February 2028 and February 2029, respectively, and will be reported at the time of vesting. The satisfaction of the 2024, 2025 and 2026 three-year earnings before interest, taxes, depreciation, and amortization ("EBITDA") PSUs and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2027, February 2028 and February 2029, respectively, and will be reported at the time of vesting.
  7. F7The satisfaction of the performance based restricted stock units granted as Deal Incentive Awards and the corresponding number of shares to be issued pursuant to these awards, will not be determined until December 2026, December 2027 and December 2028 and will be subject to additional time-based vesting conditions and, if applicable, a subsequent one-year holding period.
  8. F8These options are fully vested.
Open on SEC EDGAR
Lynn C MartinPresident, NYSE Group
4Rule 10b5-1 plan disclosed
Filed Feb 24, 2026Period of report Feb 20, 20260001193125-26-067201
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleFeb 20, 2026
Common StockF1F22,963$153.1062$453.65K64,812Direct
SaleFeb 20, 2026
Common StockF1F38,193$153.9004$1.26M56,619Direct
SaleFeb 20, 2026
Common StockF1F4F5F6F72,300$154.7156$355.85K54,319Direct
Filing footnotes · 7
  1. F1This transaction was effected pursuant to a Rule 10b5-1 trading plan which was approved and became effective as of May 29, 2025.
  2. F2The price range for the aggregate amount sold by the direct holder is $152.48 - $153.45. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price.
  3. F3The price range for the aggregate amount sold by the direct holder is $153.52 - $154.51. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price.
  4. F4The price range for the aggregate amount sold by the direct holder is $154.52 - $155.25. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price.
  5. F5The common stock number referred in Table I is an aggregate number and represents 41,398 shares of common stock and 9,805 unvested restricted stock units ("RSUs"), and 3,116 performance based restricted stock units ("PSUs"), for which the performance period has been satisfied. The RSUs and PSUs vest over a three-year period, in which 33.33% of the units vest each year.
  6. F6The satisfaction of the 2024, 2025 and 2026 TSR PSUs and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2027, February 2028 and February 2029, respectively, and will be reported at the time of vesting. The satisfaction of the 2024, 2025 and 2026 three-year earnings before interest, taxes, depreciation, and amortization ("EBITDA") PSUs and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2027, February 2028 and February 2029, respectively, and will be reported at the time of vesting.
  7. F7The satisfaction of the performance based restricted stock units granted as Deal Incentive Awards and the corresponding number of shares to be issued pursuant to these awards, will not be determined until December 2026, December 2027 and December 2028 and will be subject to additional time-based vesting conditions and, if applicable, a subsequent one-year holding period.
Open on SEC EDGAR
Christopher Scott EdmondsPresident, Fixed Income & Data
4Rule 10b5-1 plan disclosed
Filed Feb 20, 2026Period of report Feb 19, 20260001193125-26-061465
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleFeb 19, 2026
Common StockF1F24,750$153.2135$727.76K20,819Direct
SaleFeb 19, 2026
Common StockF1F34,653$153.9609$716.38K16,166Direct
SaleFeb 19, 2026
Common StockF1F41,700$154.9074$263.34K14,466Direct
SaleFeb 19, 2026
Common StockF1F5F6F7F8200$155.715$31.14K14,266Direct
Filing footnotes · 8
  1. F1This transaction was effected pursuant to a Rule 10b5-1 trading plan which was approved and became effective as of February 20, 2025.
  2. F2The price range for the aggregate amount sold by the direct holder is $152.58 - $153.56. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price.
  3. F3The price range for the aggregate amount sold by the direct holder is $153.58 - $154.57. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price.
  4. F4The price range for the aggregate amount sold by the direct holder is $154.58 - $155.25. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price.
  5. F5The price range for the aggregate amount sold by the direct holder is $155.62 - $155.81. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price.
  6. F6The common stock number referred in Table I is an aggregate number and represents 2,662 shares of common stock and 9,206 unvested restricted stock units ("RSUs"), and 2,398 performance based restricted stock units ("PSUs"), for which the performance period has been satisfied. The RSUs and PSUs vest over a three-year period, in which 33.33% of the units vest each year.
  7. F7The satisfaction of the 2024, 2025 and 2026 TSR PSUs and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2027, February 2028 and February 2029, respectively, and will be reported at the time of vesting. The satisfaction of the 2024, 2025 and 2026 three-year earnings before interest, taxes, depreciation, and amortization ("EBITDA") PSUs and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2027, February 2028 and February 2029, respectively, and will be reported at the time of vesting.
  8. F8The satisfaction of the performance based restricted stock units granted as Deal Incentive Awards and the corresponding number of shares to be issued pursuant to these awards, will not be determined until December 2026, December 2027 and December 2028 and will be subject to additional time-based vesting conditions and, if applicable, a subsequent one-year holding period.
Open on SEC EDGAR
Warren GardinerChief Financial Officer
4Rule 10b5-1 plan disclosed
Filed Feb 20, 2026Period of report Feb 19, 20260001193125-26-061462
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleFeb 19, 2026
Common StockF1F2F3F42,490$154.00$383.46K27,679Direct
Filing footnotes · 4
  1. F1This transaction was effected pursuant to a Rule 10b5-1 trading plan which was approved and became effective as of June 9, 2025.
  2. F2The common stock number referred in Table I is an aggregate number and represents 15,404 shares of common stock and 10,117 unvested restricted stock units ("RSUs"), and 2,158 performance based restricted stock units ("PSUs"), for which the performance period has been satisfied. The RSUs and PSUs vest over a three-year period, in which 33.33% of the units vest each year.
  3. F3The satisfaction of the 2024, 2025 and 2026 TSR PSUs and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2027, February 2028 and February 2029, respectively, and will be reported at the time of vesting. The satisfaction of the 2024, 2025 and 2026 three-year earnings before interest, taxes, depreciation, and amortization ("EBITDA") PSUs and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2027, February 2028 and February 2029, respectively, and will be reported at the time of vesting.
  4. F4The satisfaction of the performance based restricted stock units granted as Deal Incentive Awards and the corresponding number of shares to be issued pursuant to these awards, will not be determined until December 2026, December 2027 and December 2028 and will be subject to additional time-based vesting conditions and, if applicable, a subsequent one-year holding period.
Open on SEC EDGAR
Benjamin JacksonPresident
4Rule 10b5-1 plan disclosed
Filed Feb 20, 2026Period of report Feb 19, 20260001193125-26-061455
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleFeb 19, 2026
Common StockF1F21,919$153.1765$293.95K167,250Direct
SaleFeb 19, 2026
Common StockF1F31,246$153.8992$191.76K166,004Direct
SaleFeb 19, 2026
Common StockF1F4F5F6F7700$154.9303$108.45K165,304Direct
Filing footnotes · 7
  1. F1This transaction was effected pursuant to a Rule 10b5-1 trading plan which was approved and became effective as of November 3, 2025.
  2. F2The price range for the aggregate amount sold by the direct holder is $152.56 - $153.53. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price.
  3. F3The price range for the aggregate amount sold by the direct holder is $153.56 - $154.54. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price.
  4. F4The price range for the aggregate amount sold by the direct holder is $154.60 - $155.59. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price.
  5. F5The common stock number referred in Table I is an aggregate number and represents 143,305 shares of common stock and 17,204 unvested restricted stock units ("RSUs"), and 4,795 performance based restricted stock units ("PSUs"), for which the performance period has been satisfied. The RSUs and PSUs vest over a three-year period, in which 33.33% of the units vest each year.
  6. F6The satisfaction of the 2024, 2025 and 2026 TSR PSUs and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2027, February 2028 and February 2029, respectively, and will be reported at the time of vesting. The satisfaction of the 2024, 2025 and 2026 three-year earnings before interest, taxes, depreciation, and amortization ("EBITDA") PSUs and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2027, February 2028 and February 2029, respectively, and will be reported at the time of vesting.
  7. F7The satisfaction of the performance based restricted stock units granted as Deal Incentive Awards and the corresponding number of shares to be issued pursuant to these awards, will not be determined until December 2026, December 2027 and December 2028 and will be subject to additional time-based vesting conditions and, if applicable, a subsequent one-year holding period.
Open on SEC EDGAR
Jeffrey C SprecherDirector · Chief Executive Officer
4Rule 10b5-1 plan disclosed
Filed Feb 19, 2026Period of report Feb 17, 20260001193125-26-059907
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleFeb 18, 2026
Common StockF2F3F4F5129,937$154.9968$20.14M1,094,923Direct
SaleFeb 18, 2026
Common StockF2F6150,000$154.9968$23.25M1,651,705IndirectCPEX
Filing footnotes · 8
  1. F1Represents shares of performance based restricted stock units granted to the filing person on February 12, 2024. The vesting of the shares of performance based restricted stock units was conditioned upon the achievement of certain 2024 earnings before interest, taxes, depreciation, and amortization ("EBITDA") performance versus pre-established targets. The restricted stock units vest over three years (1/3 on February 15, 2025, 1/3 on February 15, 2026 and 1/3 on February 15, 2027). Of the 42,792 shares, 14,264 were issued on February 17, 2026, of which 6,459 shares were withheld to satisfy payment of the Issuer's tax withholding obligation. The remaining 14,264 shares are scheduled to be issued on February 12, 2027 and taxes for this future issuance will be withheld and reported at the time the shares are issued.
  2. F2This transaction was effected pursuant to a Rule 10b5-1 trading plan which was approved and became effective as of May 30, 2025.
  3. F3The common stock number referred in Table I is an aggregate number and represents 1,034,643 shares of common stock and 46,016 unvested restricted stock units ("RSUs"), and 14,264 performance based restricted stock units ("PSUs"), for which the performance period has been satisfied. The RSUs and PSUs vest over a three-year period, in which 33.33% of the units vest each year.
  4. F4The satisfaction of the 2024, 2025 and 2026 TSR PSUs and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2027, February 2028 and February 2029, respectively, and will be reported at the time of vesting. The satisfaction of the 2024, 2025 and 2026 three-year earnings before interest, taxes, depreciation, and amortization ("EBITDA") PSUs and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2027, February 2028 and February 2029, respectively, and will be reported at the time of vesting.
  5. F5The satisfaction of the performance based restricted stock units granted as Deal Incentive Awards and the corresponding number of shares to be issued pursuant to these awards, will not be determined until December 2026, December 2027 and December 2028 and will be subject to additional time-based vesting conditions and, if applicable, a subsequent one-year holding period.
  6. F6As previously reported, the reporting person also indirectly owns 1,651,705 shares that are beneficially owned directly by CPEX. The reporting person beneficially owns 100% of the equity interest in CPEX. Additionally, as previously reported, the reporting person indirectly owns shares that are beneficially owned directly by the reporting person's spouse for which the reporting person disclaims beneficial ownership.
  7. F7As previously reported, the reporting person also indirectly owns 81,570 shares that are beneficially owned directly by the reporting person's spouse for which the reporting person disclaims beneficial ownership.
  8. F8These options are fully vested.
Open on SEC EDGAR
Mayur KapaniChief Technology Officer
4Rule 10b5-1 plan disclosed
Filed Feb 19, 2026Period of report Feb 17, 20260001193125-26-059899
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleFeb 18, 2026
Common StockF2F34,519$154.4854$698.12K75,563Direct
SaleFeb 18, 2026
Common StockF2F4F5F6F710,694$155.2485$1.66M64,869Direct
Filing footnotes · 8
  1. F1Represents shares of performance based restricted stock units granted to the filing person on February 12, 2024. The vesting of the shares of performance based restricted stock units was conditioned upon the achievement of certain 2024 earnings before interest, taxes, depreciation, and amortization ("EBITDA") performance versus pre-established targets. The restricted stock units vest over three years (1/3 on February 15, 2025, 1/3 on February 15, 2026 and 1/3 on February 15, 2027). Of the 6,904 shares, 2,302 were issued on February 17, 2026, of which 1,028 shares were withheld to satisfy payment of the Issuer's tax withholding obligation. The remaining 2,302 shares are scheduled to be issued on February 12, 2027 and taxes for this future issuance will be withheld and reported at the time the shares are issued.
  2. F2This transaction was effected pursuant to a Rule 10b5-1 trading plan which was approved and became effective as of June 6, 2025.
  3. F3The price range for the aggregate amount sold by the direct holder is $153.89 - $154.88. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price.
  4. F4The price range for the aggregate amount sold by the direct holder is $154.89 - $155.84. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price.
  5. F5The common stock number referred in Table I is an aggregate number and represents 53,660 shares of common stock and 8,907 unvested restricted stock units ("RSUs"), and 2,302 performance based restricted stock units ("PSUs"), for which the performance period has been satisfied. The RSUs and PSUs vest over a three-year period, in which 33.33% of the units vest each year.
  6. F6The satisfaction of the 2024, 2025 and 2026 TSR PSUs and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2027, February 2028 and February 2029, respectively, and will be reported at the time of vesting. The satisfaction of the 2024, 2025 and 2026 three-year earnings before interest, taxes, depreciation, and amortization ("EBITDA") PSUs and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2027, February 2028 and February 2029, respectively, and will be reported at the time of vesting.
  7. F7The satisfaction of the performance based restricted stock units granted as Deal Incentive Awards and the corresponding number of shares to be issued pursuant to these awards, will not be determined until December 2026, December 2027 and December 2028 and will be subject to additional time-based vesting conditions and, if applicable, a subsequent one-year holding period.
  8. F8These options are fully vested.
Open on SEC EDGAR
Benjamin JacksonPresident
4Rule 10b5-1 plan disclosed
Filed Feb 12, 2026Period of report Feb 10, 20260001193125-26-048864
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleFeb 10, 2026
Common StockF1F212,861$165.001$2.12M165,692Direct
Filing footnotes · 8
  1. F1This transaction was effected pursuant to a Rule 10b5-1 trading plan which was approved and became effective as of November 3, 2025.
  2. F2The price range for the aggregate amount sold by the direct holder is $165.00 - $165.06. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price.
  3. F3Represents shares of restricted stock units issued to the filing person on February 10, 2025. The restricted stock units vest over three years (1/3 on February 10, 2026, 1/3 on February 10, 2027 and 1/3 on February 10, 2028). Of the 9,424 shares, 3,141 shares were issued on February 10, 2026, of which 1,413 shares were withheld to satisfy payment of the Issuer's tax withholding obligation. The remaining 6,283 shares are scheduled to be issued on the two remaining vesting dates and taxes for these future issuances will be withheld and reported at the time the shares are issued.
  4. F4Represents restricted stock units issued to the filing person on February 10, 2026. This award of restricted stock units vests over three years (1/3 on each anniversary of the award date).
  5. F5The common stock number referred in Table I is an aggregate number and represents 139,785 shares of common stock and 17,204 unvested restricted stock units ("RSUs"), and 18,211 performance based restricted stock units ("PSUs"), for which the performance period has been satisfied. The RSUs and PSUs vest over a three-year period, in which 33.33% of the units vest each year.
  6. F6The satisfaction of the 2024, 2025 and 2026 TSR PSUs and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2027, February 2028 and February 2029, respectively, and will be reported at the time of vesting. The satisfaction of the 2024, 2025 and 2026 three-year earnings before interest, taxes, depreciation, and amortization ("EBITDA") PSUs and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2027, February 2028 and February 2029, respectively, and will be reported at the time of vesting.
  7. F7The satisfaction of the performance based restricted stock units granted as Deal Incentive Awards and the corresponding number of shares to be issued pursuant to these awards, will not be determined until December 2026, December 2027 and December 2028 and will be subject to additional time-based vesting conditions and, if applicable, a subsequent one-year holding period.
  8. F8These options are fully vested
Open on SEC EDGAR
Judith a SprieserDirector
4Rule 10b5-1 plan disclosed
Filed Feb 9, 2026Period of report Feb 5, 20260001193125-26-042880
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleFeb 5, 2026
Common StockF1F2700$166.9243$116.85K13,769Direct
SaleFeb 5, 2026
Common StockF1F31,522$168.1311$255.90K12,247Direct
SaleFeb 5, 2026
Common StockF1F41,000$169.3362$169.34K11,247Direct
SaleFeb 5, 2026
Common StockF1F5300$169.9208$50.98K10,947Direct
SaleFeb 5, 2026
Common StockF1F61,000$171.254$171.25K9,947Direct
SaleFeb 5, 2026
Common StockF1100$172.02$17.20K9,847Direct
SaleFeb 5, 2026
Common StockF1F7100$173.88$17.39K9,747Direct
Filing footnotes · 7
  1. F1This transaction was effected pursuant to a Rule 10b5-1 trading plan which was approved and became effective as of June 5, 2025.
  2. F2The price range for the aggregate amount sold by the direct holder is $166.44 - $167.34. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price.
  3. F3The price range for the aggregate amount sold by the direct holder is $167.69 - $168.66. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price.
  4. F4The price range for the aggregate amount sold by the direct holder is $168.71 - $169.68. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price.
  5. F5The price range for the aggregate amount sold by the direct holder is $169.71 - $170.05. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price.
  6. F6The price range for the aggregate amount sold by the direct holder is $170.97 - $171.61. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price.
  7. F7The common stock number referred in Table I is an aggregate number and represents 8,273 shares of common stock and 1,474 restricted stock units of the Issuer. The restricted stock units vest on the one-year anniversary of the grant date, which is May 16, 2026.
Open on SEC EDGAR
Douglas FoleySVP, HR & Administration
4Rule 10b5-1 plan disclosed
Filed Dec 16, 2025Period of report Dec 12, 20250001193125-25-320944
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleDec 12, 2025
Common StockF1F2F3F41,600$163.20$261.12K24,196Direct
Filing footnotes · 4
  1. F1This transaction was effected pursuant to a Rule 10b5-1 trading plan which was approved and became effective as of November 22, 2024.
  2. F2The common stock number referred in Table I is an aggregate number and represents 19,047 shares of common stock, 1,795 unvested restricted stock units ("RSUs"), and 3,354 unvested performance based restricted stock units ("PSUs"), for which the performance period has been satisfied. The RSUs and PSUs vest over a three-year period, in which 33.33% of the units vest each year.
  3. F3The satisfaction of the 2023, 2024 and 2025 three-year total shareholder return (TSR) PSUs and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2026, February 2027 and February 2028, respectively, and will be reported at the time of vesting. The satisfaction of the 2024 and 2025 three-year earnings before interest, taxes, depreciation, and amortization (EBITDA) PSUs and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2027 and February 2028, respectively, and will be reported at the time of vesting.
  4. F4The satisfaction of the performance based restricted stock units granted as Deal Incentive Awards and the corresponding number of shares to be issued pursuant to these awards, will not be determined until December 2026, December 2027 and December 2028 and will be subject to additional time-based vesting conditions and, if applicable, a subsequent one-year holding period.
Open on SEC EDGAR
Mayur KapaniChief Technology Officer
4Rule 10b5-1 plan disclosed
Filed Dec 10, 2025Period of report Dec 8, 20250001193125-25-314286
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleDec 8, 2025
Common StockF1F23,409$156.5147$533.56K67,176Direct
SaleDec 8, 2025
Common StockF1F3F4F5F61,936$156.9337$303.82K65,240Direct
Filing footnotes · 7
  1. F1This transaction was effected pursuant to a Rule 10b5-1 trading plan which was approved and became effective as of June 6, 2025.
  2. F2The price range for the aggregate amount sold by the direct holder is $155.83 - $156.81. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price.
  3. F3The price range for the aggregate amount sold by the direct holder is $156.83 - $157.18. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price.
  4. F4The common stock number referred in Table I is an aggregate number and represents 52,317 shares of common stock and 4,487 unvested restricted stock units ("RSUs"), and 8,436 unvested performance based restricted stock units ("PSUs"), for which the performance period has been satisfied. The RSUs and PSUs vest over a three year period, in which 33.33% of the units vest each year.
  5. F5The satisfaction of the 2023, 2024 and 2025 three-year total shareholder return (TSR) PSUs and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2026, February 2027 and February 2028, respectively, and will be reported at the time of vesting. The satisfaction of the 2024 and 2025 three-year earnings before interest, taxes, depreciation, and amortization (EBITDA) PSUs and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2027 and February 2028, respectively, and will be reported at the time of vesting.
  6. F6The satisfaction of the performance based restricted stock units granted as Deal Incentive Awards and the corresponding number of shares to be issued pursuant to these awards, will not be determined until December 2026, December 2027 and December 2028 and will be subject to additional time-based vesting conditions and, if applicable, a subsequent one-year holding period.
  7. F7These options are fully vested.
Open on SEC EDGAR
Judith a SprieserDirector
4Rule 10b5-1 plan disclosed
Filed Dec 9, 2025Period of report Dec 5, 20250001193125-25-312811
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleDec 5, 2025
Common StockF1F23,300$157.8863$521.02K14,869Direct
SaleDec 5, 2025
Common StockF1F3F4400$158.5375$63.42K14,469Direct
Filing footnotes · 4
  1. F1This transaction was effected pursuant to a Rule 10b5-1 trading plan which was approved and became effective as of June 5, 2025.
  2. F2The price range for the aggregate amount sold by the direct holder is $157.40 - $158.36. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price.
  3. F3The price range for the aggregate amount sold by the direct holder is $158.40 - $158.79. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price.
  4. F4The common stock number referred in Table I is an aggregate number and represents 12,995 shares of common stock and 1,474 restricted stock units of the Issuer. The restricted stock units vest on the one-year anniversary of the grant date, which is May 16, 2026.
Open on SEC EDGAR
Warren GardinerChief Financial Officer
4Rule 10b5-1 plan disclosed
Filed Nov 24, 2025Period of report Nov 20, 20250001193125-25-293743
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleNov 20, 2025
Common StockF1F2F3F41,572$153.65$241.54K20,534Direct
Filing footnotes · 4
  1. F1This transaction was effected pursuant to a Rule 10b5-1 trading plan which was approved and became effective as of November 29, 2024.
  2. F2The common stock number referred in Table I is an aggregate number and represents 7,930 shares of common stock, 4,936 unvested restricted stock units ("RSUs"), and 7,668 unvested performance based restricted stock units ("PSUs"), for which the performance period has been satisfied. The RSUs and PSUs vest over a three-year period, in which 33.33% of the units vest each year.
  3. F3The satisfaction of the 2023, 2024 and 2025 three-year total shareholder return (TSR) PSUs and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2026, February 2027 and February 2028, respectively, and will be reported at the time of vesting. The satisfaction of the 2024 and 2025 three-year earnings before interest, taxes, depreciation, and amortization (EBITDA) PSUs and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2027 and February 2028, respectively, and will be reported at the time of vesting.
  4. F4The satisfaction of the performance based restricted stock units granted as Deal Incentive Awards and the corresponding number of shares to be issued pursuant to these awards, will not be determined until December 2026, December 2027 and December 2028 and will be subject to additional time-based vesting conditions and, if applicable, a subsequent one-year holding period.
Open on SEC EDGAR
Andrew J SurdykowskiGeneral Counsel
4Rule 10b5-1 plan disclosed
Filed Nov 21, 2025Period of report Nov 19, 20250001193125-25-291486
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleNov 19, 2025
Common StockF1F2F3F41,770$152.52$269.96K44,212Direct
Filing footnotes · 5
  1. F1This transaction was effected pursuant to a Rule 10b5-1 trading plan which was approved and became effective as of November 20, 2024.
  2. F2The common stock number referred in Table I is an aggregate number and represents 35,318 shares of common stock, 3,141 unvested restricted stock units ("RSUs"), and 5,753 unvested performance based restricted stock units ("PSUs"), for which the performance period has been satisfied. The RSUs and PSUs vest over a three-year period, in which 33.33% of the units vest each year.
  3. F3The satisfaction of the 2023, 2024 and 2025 three-year total shareholder return PSUs and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2026, February 2027 and February 2028, respectively, and will be reported at the time of vesting. The satisfaction of the 2024 and 2025 three-year EBITDA PSUs and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2027 and February 2028, respectively, and will be reported at the time of vesting.
  4. F4The satisfaction of the performance based restricted stock units granted as Deal Incentive Awards and the corresponding number of shares to be issued pursuant to these awards, will not be determined until December 2026, December 2027 and December 2028 and will be subject to additional time-based vesting conditions and, if applicable, a subsequent one-year holding period.
  5. F5These options are fully vested.
Open on SEC EDGAR
Jeffrey C SprecherDirector · Chief Executive Officer
4Rule 10b5-1 plan disclosed
Filed Nov 21, 2025Period of report Nov 19, 20250001193125-25-291459
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleNov 19, 2025
Common StockF5F660,639$152.621$9.25M1,891,066IndirectCPEX
SaleNov 19, 2025
Common StockF5F7F889,361$153.398$13.71M1,801,705IndirectCPEX
Filing footnotes · 9
  1. F1This transaction involved a gift of 46,000 shares of the issuer's common stock by the reporting person to a philanthropic organization.
  2. F2The common stock number referred in Table I is an aggregate number and represents 1,033,262 shares of common stock, 26,702 unvested restricted stock units ("RSUs"), and 57,027 unvested performance based restricted stock units ("PSUs"), for which the performance period has been satisfied. The RSUs and PSUs vest over a three-year period, in which 33.33% of the units vest each year.
  3. F3The satisfaction of the 2023, 2024 and 2025 three-year total shareholder return (TSR) PSUs and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2026, February 2027 and February 2028, respectively, and will be reported at the time of vesting. The satisfaction of the 2024 and 2025 three-year earnings before interest, taxes, depreciation, and amortization (EBITDA) PSUs and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2027 and February 2028, respectively, and will be reported at the time of vesting.
  4. F4The satisfaction of the performance based restricted stock units granted as Deal Incentive Awards and the corresponding number of shares to be issued pursuant to these awards, will not be determined until December 2026, December 2027 and December 2028 and will be subject to additional time-based vesting conditions and, if applicable, a subsequent one-year holding period.
  5. F5This transaction was effected pursuant to a Rule 10b5-1 trading plan which was approved and became effective as of May 30, 2025.
  6. F6The price range for the aggregate amount sold by the direct holder is $152.00 - $152.99. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price.
  7. F7The price range for the aggregate amount sold by the direct holder is $153.00 - $153.65. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price.
  8. F8As previously reported, the reporting person also indirectly owns 1,801,705 shares that are beneficially owned directly by CPEX. The reporting person beneficially owns 100% of the equity interest in CPEX. Additionally, as previously reported, the reporting person indirectly owns shares that are beneficially owned directly by the reporting person's spouse for which the reporting person disclaims beneficial ownership.
  9. F9As previously reported, the reporting person also indirectly owns 81,570 shares that are beneficially owned directly by the reporting person's spouse for which the reporting person disclaims beneficial ownership.
Open on SEC EDGAR

P and S transaction codes only. Grants, gifts, option exercises, tax withholding, and Form 144 notices are not counted as purchases or sales. A row whose filed price fails a plausibility check, or that is not common stock, is listed but left out of the values; a trade reported by several filers is counted once.